share_log

Urovo Technology (SZSE:300531) Shareholders Are up 24% This Past Week, but Still in the Red Over the Last Five Years

Urovo Technology (SZSE:300531) Shareholders Are up 24% This Past Week, but Still in the Red Over the Last Five Years

優博訊(SZSE:300531)股東上週增長了24%,但在過去五年中仍處於虧損狀態。
Simply Wall St ·  07/25 18:55

Urovo Technology Co., Ltd. (SZSE:300531) shareholders should be happy to see the share price up 24% in the last week. But if you look at the last five years the returns have not been good. After all, the share price is down 34% in that time, significantly under-performing the market.

優博訊科技股份有限公司(SZSE:300531)的股東應該很高興,因爲最近一週股價上漲了24%。但如果你看過去五年的表現,會發現回報並不好。畢竟,在那段時間內,股價下跌了34%,表現顯著低於市場水平。

On a more encouraging note the company has added CN¥706m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.

更令人鼓舞的是,公司僅在過去7天內就爲市值增加了70600萬人民幣,所以讓我們看看是什麼推動了股東五年的虧損。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

雖然一些人仍然相信有效市場假說,但已經證明市場是過度反應的動態系統,投資者並不總是理性的。一個不完美但簡單的方法來考慮公司市場看法的變化是比較每股收益(EPS)的變化和股價的波動。

Over five years Urovo Technology's earnings per share dropped significantly, falling to a loss, with the share price also lower. The recent extraordinary items contributed to this situation. Since the company has fallen to a loss making position, it's hard to compare the change in EPS with the share price change. However, we can say we'd expect to see a falling share price in this scenario.

在五年內,優博訊科技每股收益出現了大幅下降,導致股價也下跌。最近的非常項目加劇了這種情況。由於公司已陷入虧損的境地,很難將EPS變化與股價變化進行比較。但是,我們可以說,在這種情況下,我們預計會看到股價下跌。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨時間的推移)如下圖所示(單擊可查看確切數字)。

big
SZSE:300531 Earnings Per Share Growth July 25th 2024
SZSE:300531每股收益增長2024年7月25日

This free interactive report on Urovo Technology's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

如果您想進一步調查該股票,請查看優博訊科技的收益、營業收入和現金流的免費互動報告。

A Different Perspective

不同的觀點

Although it hurts that Urovo Technology returned a loss of 16% in the last twelve months, the broader market was actually worse, returning a loss of 19%. Given the total loss of 6% per year over five years, it seems returns have deteriorated in the last twelve months. While some investors do well specializing in buying companies that are struggling (but nonetheless undervalued), don't forget that Buffett said that 'turnarounds seldom turn'. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for Urovo Technology that you should be aware of before investing here.

儘管優博訊科技在過去十二個月裏回報了-16%,但整個市場的表現實際上更差,回報爲-19%。考慮到五年內總共的6%虧損,似乎在過去十二個月中回報已經惡化了。雖然有些投資者擅長於買入那些陷入困境但被低估的公司,但切勿忘記巴菲特曾說過“轉機很少成爲轉機”。我發現用股價作爲業務表現的代理長期觀察很有趣。但爲了真正獲得洞見,我們還需要考慮其他信息。例如,我們發現了一項關於優博訊科技的警告信號,您在此投資之前應該知道。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

如果您願意查看另一家公司(具有潛在的更好財務狀況),請不要錯過這個免費的公司列表,證明它們可以增長收益。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論